{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:18:21Z","timestamp":1792732701390,"version":"4.5.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jconrel.2026.115170","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:17:20Z","timestamp":1784042240000},"page":"115170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Advances in RNA delivery to extrahepatic tissues and cells"],"prefix":"10.1016","volume":"397","author":[{"given":"Zhengyue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0005","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41573-025-01237-x","article-title":"RNA chemistry and therapeutics [J]","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s43556-023-00160-0","article-title":"Delivery of nucleic acids using nanomaterials [J]","volume":"4","author":"Qin","year":"2023","journal-title":"Mol. Biomed."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13311-019-00736-1","article-title":"Nucleic acid therapeutics for neurological diseases [J]","volume":"16","author":"Watts","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0020","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ymthe.2025.02.047","article-title":"Using aptamers for targeted delivery of RNA therapies [J]","volume":"33","author":"Driscoll","year":"2025","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115170_bb0025","first-page":"167","article-title":"Nanoscale delivery platforms for RNA therapeutics: challenges and the current state of the art [J]","volume":"3","author":"Rhym","year":"2022","journal-title":"Med-Cambridge"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/nat.2016.0607","article-title":"Pharmacokinetic and pharmacodynamic investigations of ION-353382, a model antisense oligonucleotide: using alpha-2-macroglobulin and murinoglobulin double-knockout mice [J]","volume":"26","author":"Shemesh","year":"2016","journal-title":"Nucleic Acid Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molmed.2023.10.005","article-title":"Three \u2018E\u2019 challenges for siRNA drug development [J]","volume":"30","author":"Guo","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0040","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation [J]","volume":"15","author":"Su","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1039\/D4MD00652F","article-title":"Hepatocyte targeting via the asialoglycoprotein receptor [J]","volume":"16","author":"Ram\u00edrez-Cort\u00e9s","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41392-024-02035-4","article-title":"Nucleic acid drugs: recent progress and future perspectives [J]","volume":"9","author":"Sun","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery [J]","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics [J]","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115170_bb0065","first-page":"218","article-title":"Advances in locally administered nucleic acid therapeutics [J]","volume":"49","author":"Shen","year":"2025","journal-title":"Bioact. Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13092167","article-title":"Intrathecal therapies for neurodegenerative diseases: a review of current approaches and the urgent need for advanced delivery systems [J]","volume":"13","author":"Schreiner","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0075","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1038\/s41467-025-63553-5","article-title":"Ocular delivery of lipid nanoparticles-formulated mRNA encoding lanosterol synthase ameliorates cataract in rats [J]","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115170_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-026-02188-z","article-title":"Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-\u03b2-coronavirus protection [J]","author":"Liu","year":"2026","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115170_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery [J]","volume":"351","author":"Zimmermann","year":"2022","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115170_bb0090","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","article-title":"Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting [J]","volume":"31","author":"Anttila","year":"2023","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases [J]","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Tar."},{"key":"10.1016\/j.jconrel.2026.115170_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"eBioMedicine"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115170_bb0105","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery [J]","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115170_bb0110","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41551-025-01511-8","article-title":"Targeting and tracking mRNA lipid nanoparticles at the particle, transcript and protein level [J]","volume":"9","author":"Kang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115170_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105837","article-title":"Inflammation-modulating polymeric nanoparticles: design strategies, mechanisms, and therapeutic applications [J]","volume":"118","author":"Zhang","year":"2025","journal-title":"EBioMedicine"},{"issue":"18","key":"10.1016\/j.jconrel.2026.115170_bb0120","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1080\/17435889.2025.2542110","article-title":"Emerging polymeric nanocarriers for mRNA and protein therapeutics: design, challenges, and clinical outlook [J]","volume":"20","author":"Forenzo","year":"2025","journal-title":"Nanomedicine (London)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","article-title":"Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies [J]","volume":"10","author":"Xu","year":"2025","journal-title":"Signal. Transduct. Tar."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0130","article-title":"Extracellular vesicle-based mRNA therapeutics and vaccines [J]","volume":"5","author":"Li","year":"2025","journal-title":"Exploration (Beijing)"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0135","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41563-023-01472-w","article-title":"Hydrogels for RNA delivery [J]","volume":"22","author":"Zhong","year":"2023","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115170_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.08.014","article-title":"Nucleic acid-based therapy for brain cancer: challenges and strategies [J]","volume":"350","author":"Zhang","year":"2022","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0145","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1021\/acsnano.3c04507","article-title":"Fluorinated lipid nanoparticles for enhancing mRNA delivery efficiency [J]","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115170_bb0150","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized nanomaterials capable of crossing the blood\u2013brain barrier [J]","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115170_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121584","article-title":"Nanomedicines for pulmonary drug delivery: overcoming barriers in the treatment of respiratory infections and lung cancer [J]","volume":"16","author":"Fern\u00e1ndez-Garc\u00eda","year":"2024","journal-title":"Pharmaceutics"},{"issue":"18","key":"10.1016\/j.jconrel.2026.115170_bb0160","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1016\/j.cell.2024.07.012","article-title":"A systems view of the vascular endothelium in health and disease [J]","volume":"187","author":"Augustin","year":"2024","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: A bottleneck for LNP-mediated therapeutics [J]","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115170_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114362","article-title":"Non-cationic carriers for siRNA delivery: current progress and potential applications [J]","volume":"388","author":"Fan","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00253-025-13620-0","article-title":"MiRNA-based drugs: challenges and delivery strategies [J]","volume":"109","author":"Wang","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115170_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery [J]","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0185","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41587-024-02437-3","article-title":"Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR\u2013Cas9 ribonucleoprotein [J]","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0190","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1038\/s41467-025-58523-w","article-title":"Liposomal lipid nanoparticles for extrahepatic delivery of mRNA [J]","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115170_bb0195","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.1021\/acsnano.5c19757","article-title":"The impact of polyethylene glycol lipid anchors on the physicochemical properties, protein corona, function, and biodistribution of lipid nanoparticles [J]","volume":"20","author":"Lu","year":"2026","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism [J]","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115170_bb0205","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41423-025-01298-3","article-title":"Liver macrophages: development, dynamics, and functions [J]","volume":"22","author":"Nusse","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0210","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.apsb.2024.05.008","article-title":"Current status and trends in small nucleic acid drug development: leading the future [J]","volume":"14","author":"Miao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0215","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1021\/jacs.3c11914","article-title":"Organ\/cell-selective intracellular delivery of biologics via N-acetylated galactosamine-functionalized polydisulfide conjugates [J]","volume":"146","author":"Lu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jcph.2337","article-title":"Pharmacokinetics and pharmacodynamics of GalNAc-conjugated siRNAs [J]","volume":"64","author":"An","year":"2024","journal-title":"J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115170_bb0225","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.3390\/ijms26083456","article-title":"Recent update on siRNA therapeutics [J]","volume":"26","author":"Ebenezer","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1099","key":"10.1016\/j.jconrel.2026.115170_bb0230","first-page":"229","article-title":"Recycling of the asialoglycoprotein receptor: biochemical and immunocytochemical evidence [J]","volume":"300","author":"Schwartz","year":"1982","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010109","article-title":"Targeting brain drug delivery with macromolecules through receptor-mediated transcytosis [J]","volume":"17","author":"Li","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13195-025-01840-5","article-title":"Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer\u2019s disease in a mouse model [J]","volume":"17","author":"Pan","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.jconrel.2026.115170_bb0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications [J]","volume":"203","author":"D\u2019Souza","year":"2015","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA [J]","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0255","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41580-025-00852-1","article-title":"Functions and therapeutic applications of pseudouridylation [J]","volume":"26","author":"Luo","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0260","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.3390\/ijms25073595","article-title":"mRNA-LNP COVID-19 vaccine lipids induce complement activation and production of proinflammatory cytokines: mechanisms, effects of complement inhibitors, and relevance to adverse reactions [J]","volume":"25","author":"Bakos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0265","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbrc.2004.04.175","article-title":"Many commonly used siRNAs risk off-target activity [J]","volume":"319","author":"Sn\u00f8ve","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy [J]","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0275","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/ijms25021050","article-title":"Delivery of adeno-associated virus vectors to the central nervous system for correction of single gene disorders [J]","volume":"25","author":"Daci","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity [J]","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0285","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12951-026-04368-4","article-title":"Therapeutic potential of ADAR1-regulated macrophage exosomes for improving myocardial damage in septic cardiomyopathy [J]","volume":"24","author":"Wang","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0290","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system [J]","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0295","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2020.1840913","article-title":"Basic physiology of the blood-brain barrier in health and disease: a brief overview [J]","volume":"9","author":"Kaya","year":"2021","journal-title":"Tissue Barriers"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0300","first-page":"6","article-title":"Non-viral approaches for gene therapy and therapeutic genome editing across the blood-brain barrier [J]","volume":"1","author":"Xie","year":"2023","journal-title":"Med X"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115170_bb0305","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","article-title":"Precision drug delivery to the central nervous system using engineered nanoparticles [J]","volume":"9","author":"Gao","year":"2024","journal-title":"Nat. Rev. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115170_bb0310","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: Vector toolkit for human gene therapy [J]","volume":"14","author":"Wu","year":"2006","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0315","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/gt.2016.62","article-title":"Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism [J]","volume":"23","author":"Powell","year":"2016","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115170_bb0320","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/00001756-200008210-00013","article-title":"Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors [J]","volume":"11","author":"Alisky","year":"2000","journal-title":"Neuroreport"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0325","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","article-title":"Onasemnogene abeparvovec: first global approval [J]","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier [J]","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9923","key":"10.1016\/j.jconrel.2026.115170_bb0335","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","article-title":"Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial [J]","volume":"383","author":"Palfi","year":"2014","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.jconrel.2026.115170_bb0340","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1089\/104303400750035726","article-title":"Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses [J]","volume":"11","author":"Sandmair","year":"2000","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0345","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain [J]","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0350","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ymthe.2019.02.013","article-title":"The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier [J]","volume":"27","author":"Hordeaux","year":"2019","journal-title":"Mol. Ther."},{"issue":"6701","key":"10.1016\/j.jconrel.2026.115170_bb0355","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.adm8386","article-title":"An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery [J]","volume":"384","author":"Huang","year":"2024","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115170_bb0360","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","article-title":"Directed evolution of adeno-associated virus for efficient gene delivery to microglia [J]","volume":"19","author":"Lin","year":"2022","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0365","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41434-019-0075-6","article-title":"Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury [J]","volume":"26","author":"Griffin","year":"2019","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0370","first-page":"1150","article-title":"Efficient and durable gene delivery of self complementary adeno-associated virus 6 vector and impact of pre-existing immunity","volume":"29","author":"Tu","year":"2012","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0375","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ymthe.2024.02.002","article-title":"High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury [J]","volume":"32","author":"Hordeaux","year":"2024","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0380","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI34316","article-title":"Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice [J]","volume":"118","author":"Allocca","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115170_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115363","article-title":"Adeno-associated virus vector delivery to the brain: technology advancements and clinical applications [J]","volume":"211","author":"Ye","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020342","article-title":"Delivery of oligonucleotides: efficiency with lipid conjugation and clinical outcome [J]","volume":"14","author":"Tran","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0395","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2012.08.012","article-title":"Focused ultrasound for targeted delivery of siRNA and efficient knockdown of expression [J]","volume":"163","author":"Burgess","year":"2012","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115170_bb0400","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates [J]","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0405","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001787R","article-title":"Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1 [J]","volume":"35","author":"Stocki","year":"2021","journal-title":"FASEB J."},{"issue":"760","key":"10.1016\/j.jconrel.2026.115170_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi2245","article-title":"Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier [J]","volume":"16","author":"Barker","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.jconrel.2026.115170_bb0415","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1039\/D2BM00368F","article-title":"Development of non-viral vectors for neuronal-targeted delivery of CRISPR-Cas9 RNA-proteins as a therapeutic strategy for neurological disorders [J]","volume":"10","author":"Shalaby","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115170_bb0420","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes [J]","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0425","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molmed.2023.02.004","article-title":"Brain gene therapy with Trojan horse lipid nanoparticles [J]","volume":"29","author":"Pardridge","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0430","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s13346-023-01482-w","article-title":"ApoE-functionalization of nanoparticles for targeted brain delivery-a feasible method for polyplexes? [J]","volume":"14","author":"Hartl","year":"2024","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0435","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1021\/acs.molpharmaceut.7b01084","article-title":"In vivo introduction of mRNA encapsulated in lipid nanoparticles to brain neuronal cells and astrocytes via intracerebroventricular administration [J]","volume":"15","author":"Tanaka","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115170_bb0440","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system [J]","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"30","key":"10.1016\/j.jconrel.2026.115170_bb0445","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4429","article-title":"Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection [J]","volume":"6","author":"Ma","year":"2020","journal-title":"Sci. Adv."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115170_bb0450","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1021\/acsnano.3c02268","article-title":"Ionizable lipid nanoparticles for therapeutic base editing of congenital brain disease [J]","volume":"17","author":"Palanki","year":"2023","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0455","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery [J]","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115170_bb0460","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","article-title":"Polyethylenimine nanoparticle-mediated siRNA delivery to reduce \u03b1-synuclein expression in a model of Parkinson\u2019s disease [J]","volume":"9","author":"Helmschrodt","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0465","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s12274-016-1055-4","article-title":"In vitro studies of polyethyleneimine coated miRNA microspheres as anticancer agents [J]","volume":"9","author":"Rytblat","year":"2016","journal-title":"Nano Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0470","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-022-01298-z","article-title":"Nucleic acid drug vectors for diagnosis and treatment of brain diseases [J]","volume":"8","author":"Lu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115170_bb0475","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2015.12.034","article-title":"Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound [J]","volume":"223","author":"Mead","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115170_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121359","article-title":"SHMT1 siRNA-Loaded hyperosmotic nanochains for blood-brain\/tumor barrier post-transmigration therapy [J]","volume":"281","author":"Pandey","year":"2022","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.jconrel.2026.115170_bb0485","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.biomaterials.2011.03.047","article-title":"A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA [J]","volume":"32","author":"Hwang","year":"2011","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0490","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23584","article-title":"A facile and scalable method to synthesize PEGylated PDMAEMA for gene delivery [J]","volume":"115","author":"Dou","year":"2024","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2026.115170_bb0495","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.actbio.2016.11.029","article-title":"A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer\u2019s disease mice [J]","volume":"49","author":"Zheng","year":"2017","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0500","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1039\/C9NR06187H","article-title":"Polyornithine-based polyplexes to boost effective gene silencing in CNS disorders [J]","volume":"12","author":"Conejos-S\u00e1nchez","year":"2020","journal-title":"Nanoscale"},{"issue":"32","key":"10.1016\/j.jconrel.2026.115170_bb0505","doi-asserted-by":"crossref","first-page":"15339","DOI":"10.1039\/C8NR03976C","article-title":"Systemic siRNA delivery to tumors by cell-penetrating \u03b1-helical polypeptide-based metastable nanoparticles [J]","volume":"10","author":"Liu","year":"2018","journal-title":"Nanoscale"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0510","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1021\/cr500542t","article-title":"Surface-engineered dendrimers in gene delivery [J]","volume":"115","author":"Yang","year":"2015","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0515","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/mt.2011.291","article-title":"Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain [J]","volume":"20","author":"Kim","year":"2012","journal-title":"Mol. Ther."},{"issue":"27","key":"10.1016\/j.jconrel.2026.115170_bb0520","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909999","article-title":"Endo\/lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer\u2019s disease [J]","volume":"30","author":"Cai","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115170_bb0525","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.actbio.2016.12.048","article-title":"Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson\u2019s Disease (PD) [J]","volume":"54","author":"Sheikh","year":"2017","journal-title":"Acta Biomater."},{"issue":"6478","key":"10.1016\/j.jconrel.2026.115170_bb0530","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes [J]","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0535","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","article-title":"Therapeutically harnessing extracellular vesicles [J]","volume":"21","author":"Cheng","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115170_bb0540","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40364-019-0159-x","article-title":"Exosomes from mesenchymal stem\/stromal cells: a new therapeutic paradigm [J]","volume":"7","author":"Yin","year":"2019","journal-title":"Biomark. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0545","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jconrel.2011.11.021","article-title":"Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery [J]","volume":"161","author":"van Dommelen","year":"2012","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0550","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors [J]","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115170_bb0555","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications [J]","volume":"21","author":"O\u2019Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0560","doi-asserted-by":"crossref","first-page":"61","DOI":"10.31083\/ph.2021.0128","article-title":"Drug loading techniques for exosome-based drug delivery systems [J]","volume":"76","author":"Xi","year":"2021","journal-title":"Pharmazie"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115170_bb0565","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.ymthe.2018.05.024","article-title":"Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles [J]","volume":"26","author":"Haraszti","year":"2018","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0570","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.celrep.2014.08.027","article-title":"Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes [J]","volume":"8","author":"Koppers-Lalic","year":"2014","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0575","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J]","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115170_bb0580","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.2147\/IJN.S506793","article-title":"Intranasal delivery of BACE1 siRNA and berberine via engineered stem cell exosomes for the treatment of Alzheimer\u2019s disease [J]","volume":"20","author":"Sun","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115170_bb0585","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20198735","article-title":"Exosomes secreted from miRNA-29b-modified mesenchymal stem cells repaired spinal cord injury in rats [J]","volume":"52","author":"Yu","year":"2019","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0590","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s12975-017-0599-2","article-title":"Human neural stem cell extracellular vesicles improve tissue and functional recovery in the murine thromboembolic stroke model [J]","volume":"9","author":"Webb","year":"2018","journal-title":"Transl. Stroke Res."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115170_bb0595","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2174\/1570159X19666210113152108","article-title":"Targeting glioblastoma: the current state of different therapeutic approaches [J]","volume":"19","author":"Khan","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"19","key":"10.1016\/j.jconrel.2026.115170_bb0600","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.3390\/ijms21197111","article-title":"Injectable thermo-sensitive chitosan hydrogel containing CPT-11-loaded EGFR-targeted graphene oxide and SLP2 shrna for localized drug\/gene delivery in glioblastoma therapy [J]","volume":"21","author":"Lu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115170_bb0605","article-title":"Lymph node-inspired immunoregulatory hydrogel with siRNA delivery property for postoperative glioblastoma treatment [J]","volume":"476","author":"Wang","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"Pt 1","key":"10.1016\/j.jconrel.2026.115170_bb0610","article-title":"Synergistic effect of Yes-associated protein siRNA and temozolomide against glioblastoma using a localized nano delivery system [J]","volume":"321","author":"Foroohari","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115170_bb0615","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jconrel.2023.12.003","article-title":"MicroRNA-195 liposomes for therapy of Alzheimer\u2019s disease [J]","volume":"365","author":"Su","year":"2024","journal-title":"J. Control. Release"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115170_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910357","article-title":"In vivo evaluation of nose-to-brain delivery of liposomal donepezil, memantine, and BACE-1 siRNA for Alzheimer\u2019s disease therapy [J]","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0625","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nrneurol.2014.100","article-title":"MGMT testing--the challenges for biomarker-based glioma treatment [J]","volume":"10","author":"Wick","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"16","key":"10.1016\/j.jconrel.2026.115170_bb0630","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1702736114","article-title":"Dual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo [J]","volume":"114","author":"Sita","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115170_bb0635","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2022.03.036","article-title":"Heme oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy [J]","volume":"345","author":"Rehman","year":"2022","journal-title":"J. Control. Release"},{"issue":"45","key":"10.1016\/j.jconrel.2026.115170_bb0640","article-title":"Cation-free siRNA micelles as effective drug delivery platform and potent RNAi nanomedicines for glioblastoma therapy [J]","volume":"33","author":"Jiang","year":"2021","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0645","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1021\/acsnano.1c09794","article-title":"Nano-codelivery of temozolomide and siPD-L1 to reprogram the drug-resistant and immunosuppressive microenvironment in orthotopic glioblastoma [J]","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.jconrel.2026.115170_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201705054","article-title":"Traceable nanoparticles with dual targeting and ROS response for RNAi-based immunochemotherapy of intracranial glioblastoma treatment [J]","volume":"30","author":"Qiao","year":"2018","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0655","doi-asserted-by":"crossref","first-page":"18327","DOI":"10.1021\/acsnano.1c07587","article-title":"A microfluidics-based scalable approach to generate extracellular vesicles with enhanced therapeutic microRNA loading for intranasal delivery to mouse glioblastomas [J]","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0660","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1021\/acs.nanolett.2c00191","article-title":"Lipoprotein-inspired nanoscavenger for the three-pronged modulation of microglia-derived neuroinflammation in Alzheimer\u2019s disease therapy [J]","volume":"22","author":"Zhang","year":"2022","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0665","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201901555","article-title":"An \u201camyloid-\u03b2 cleaner\u201d for the treatment of Alzheimer\u2019s disease by normalizing microglial dysfunction [J]","volume":"7","author":"Liu","year":"2020","journal-title":"Adv. Sci."},{"issue":"50","key":"10.1016\/j.jconrel.2026.115170_bb0670","doi-asserted-by":"crossref","first-page":"eaba3967","DOI":"10.1126\/sciadv.aba3967","article-title":"Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson\u2019s disease [J]","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"issue":"27","key":"10.1016\/j.jconrel.2026.115170_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202101993","article-title":"Traceable nano-biohybrid complexes by one-step synthesis as CRISPR-chem vectors for neurodegenerative diseases synergistic treatment [J]","volume":"33","author":"Shen","year":"2021","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0680","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.tibtech.2024.05.002","article-title":"Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases [J]","volume":"42","author":"Zhang","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115170_bb0685","first-page":"0291","article-title":"AAV for gene therapy in ocular diseases: progress and prospects [J]","volume":"6","author":"He","year":"2023","journal-title":"Research (Wash D C)"},{"issue":"13","key":"10.1016\/j.jconrel.2026.115170_bb0690","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/s41433-024-03065-6","article-title":"Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice [J]","volume":"38","author":"Testa","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jconrel.2026.115170_bb0695","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2021.10.024","article-title":"Silencing nogo-B improves the integrity of blood-retinal barrier in diabetic retinopathy via regulating Src, PI3K\/Akt and ERK pathways [J]","volume":"581","author":"Yang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115170_bb0700","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ymthe.2019.12.012","article-title":"Gene therapy for glaucoma by ciliary body aquaporin 1 disruption using CRISPR-Cas9 [J]","volume":"28","author":"Wu","year":"2020","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0705","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.ymthe.2018.04.017","article-title":"In situ gene therapy via AAV-CRISPR-Cas9-mediated targeted gene regulation [J]","volume":"26","author":"Moreno","year":"2018","journal-title":"Mol. Ther."},{"issue":"10153","key":"10.1016\/j.jconrel.2026.115170_bb0710","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration [J]","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0715","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/nsr\/nwaa033","article-title":"CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration [J]","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0720","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12951-026-04141-7","article-title":"Mucoadhesive and corneal permeable nano eye drops for improved anti-glaucoma therapy [J]","volume":"24","author":"Zhang","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0725","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202407383","article-title":"Muco-penetrating lipid nanoparticles having a liquid core for enhanced intranasal mRNA delivery [J]","volume":"12","author":"Maniyamgama","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0730","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/10717544.2022.2048134","article-title":"Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study [J]","volume":"29","author":"Luo","year":"2022","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0735","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1039\/D0BM01599G","article-title":"Dasatinib loaded nanostructured lipid carriers for effective treatment of corneal neovascularization [J]","volume":"9","author":"Li","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115170_bb0740","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye [J]","volume":"303","author":"Patel","year":"2019","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0745","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates [J]","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0750","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.13.7.7","article-title":"Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues [J]","volume":"13","author":"Chambers","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115170_bb0755","article-title":"Trimethyl chitosan-hyaluronic acid nano-polyplexes for intravitreal VEGFR-2 siRNA delivery: formulation and in vivo efficacy evaluation [J]","volume":"26","author":"Chaharband","year":"2020","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0760","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1167\/iovs.10-5891","article-title":"A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model [J]","volume":"52","author":"Liu","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0765","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1021\/acs.nanolett.9b02596","article-title":"Octopus-like flexible vector for noninvasive intraocular delivery of short interfering nucleic acids [J]","volume":"19","author":"Jiang","year":"2019","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0770","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/pharmaceutics14020243","article-title":"MicroRNA-539-5p-loaded PLGA nanoparticles grafted with iRGD as a targeting treatment for choroidal neovascularization [J]","volume":"14","author":"Alanazi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115170_bb0775","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.actbio.2021.07.053","article-title":"A core-shell nanoplatform as a nonviral vector for targeted delivery of genes to the retina [J]","volume":"134","author":"Tan","year":"2021","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0780","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41232-023-00260-y","article-title":"Accelerating corneal wound healing using exosome-mediated targeting of NF-\u03baB c-Rel [J]","volume":"43","author":"Zhao","year":"2023","journal-title":"Inflamm. Regen."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb0785","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj9617","article-title":"miR-204-containing exosomes ameliorate GVHD-associated dry eye disease [J]","volume":"8","author":"Zhou","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0790","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12951-024-03079-y","article-title":"Exosome-loading miR-205: a two-pronged approach to ocular neovascularization therapy [J]","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0795","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/s41551-023-01112-3","article-title":"Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases [J]","volume":"8","author":"Bao","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb0800","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1039\/D5BM00322A","article-title":"Non-viral mRNA delivery to the lungs [J]","volume":"13","author":"Healy","year":"2025","journal-title":"Biomater. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0805","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing [J]","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0810","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","article-title":"Strategies for non-viral vectors targeting organs beyond the liver [J]","volume":"19","author":"Kim","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0815","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing [J]","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"52","key":"10.1016\/j.jconrel.2026.115170_bb0820","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles [J]","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0825","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41587-025-02675-z","article-title":"Dual SORT LNPs for multi-organ base editing [J]","volume":"44","author":"Kim","year":"2026","journal-title":"Nat. Biotechnol."},{"issue":"26","key":"10.1016\/j.jconrel.2026.115170_bb0830","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312026","article-title":"Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions [J]","volume":"36","author":"Omo-Lamai","year":"2024","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115170_bb0835","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis [J]","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"26","key":"10.1016\/j.jconrel.2026.115170_bb0840","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1021\/acs.nanolett.4c01854","article-title":"Lung-specific mRNA delivery enabled by sulfonium lipid nanoparticles [J]","volume":"24","author":"Popoola","year":"2024","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0845","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","article-title":"Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery [J]","volume":"20","author":"Xue","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0850","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs [J]","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115170_bb0855","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus [J]","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0860","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation [J]","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"issue":"29","key":"10.1016\/j.jconrel.2026.115170_bb0865","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400509","article-title":"Inhalable dry powders for lung mRNA delivery [J]","volume":"13","author":"Gordon","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115170_bb0870","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study [J]","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jconrel.2026.115170_bb0875","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.colsurfb.2015.08.025","article-title":"Biodegradable and versatile polyethylenimine derivatives efficiently transfer DNA and siRNA into mammalian cells [J]","volume":"135","author":"Bansal","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"32","key":"10.1016\/j.jconrel.2026.115170_bb0880","doi-asserted-by":"crossref","first-page":"35835","DOI":"10.1021\/acsami.0c08268","article-title":"Surface-functionalized PEGylated nanoparticles deliver messenger RNA to pulmonary immune cells [J]","volume":"12","author":"Ke","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"25","key":"10.1016\/j.jconrel.2026.115170_bb0885","doi-asserted-by":"crossref","first-page":"17365","DOI":"10.1021\/jacs.4c04565","article-title":"A lung-expressing mRNA delivery platform with tunable activity in hypoxic environments [J]","volume":"146","author":"Tiwade","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115170_bb0890","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy [J]","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"28","key":"10.1016\/j.jconrel.2026.115170_bb0895","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy [J]","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115170_bb0900","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/mp100390w","article-title":"In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles [J]","volume":"8","author":"Su","year":"2011","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115170_bb0905","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-021-00822-w","article-title":"Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents [J]","volume":"39","author":"Blanchard","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"44","key":"10.1016\/j.jconrel.2026.115170_bb0910","doi-asserted-by":"crossref","first-page":"13808","DOI":"10.1002\/anie.201608450","article-title":"Polymer-lipid nanoparticles for systemic delivery of mRNA to the lungs [J]","volume":"55","author":"Kaczmarek","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115170_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120780","article-title":"PEGylation of poly(amine-co-ester) polyplexes for tunable gene delivery [J]","volume":"272","author":"Grun","year":"2021","journal-title":"Biomaterials"},{"issue":"709","key":"10.1016\/j.jconrel.2026.115170_bb0920","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0603","article-title":"Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination [J]","volume":"15","author":"Suberi","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0925","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s12015-025-10888-7","article-title":"Post-myocardial infarction cardiac remodeling: multidimensional mechanisms and clinical prospects of stem cell therapy [J]","volume":"21","author":"Yong","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0930","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4331\/wjbc.v1.i5.69","article-title":"Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction [J]","volume":"1","author":"Matsui","year":"2010","journal-title":"World J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0935","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202100942","article-title":"Factors influencing retention of injected biomaterials to treat myocardial infarction [J]","volume":"9","author":"Schotman","year":"2022","journal-title":"Adv. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0940","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00395-023-01000-6","article-title":"The heterocellular heart: identities, interactions, and implications for cardiology [J]","volume":"118","author":"Lother","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jconrel.2026.115170_bb0945","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","article-title":"Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles [J]","volume":"343","author":"Evers","year":"2022","journal-title":"J. Control. Release"},{"issue":"25","key":"10.1016\/j.jconrel.2026.115170_bb0950","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1161\/CIRCULATIONAHA.120.047211","article-title":"Specific modified mRNA translation system [J]","volume":"142","author":"Magadum","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb0955","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s12265-023-10392-8","article-title":"Optimization of strategy for modified mRNA inducing cardiac-specific expression in mice [J]","volume":"16","author":"Huang","year":"2023","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0960","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41573-021-00355-6","article-title":"VEGFA mRNA for regenerative treatment of heart failure [J]","volume":"21","author":"Coll\u00e9n","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115170_bb0965","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2024.06.023","article-title":"Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: advances in genome editing and CAR T cell therapy [J]","volume":"372","author":"Soroudi","year":"2024","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb0970","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/jpm12071021","article-title":"Relaxin-2 as a potential biomarker in cardiovascular diseases [J]","volume":"12","author":"Arag\u00f3n-Herrera","year":"2022","journal-title":"J. Pers. Med."},{"issue":"6576","key":"10.1016\/j.jconrel.2026.115170_bb0975","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury [J]","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115170_bb0980","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2023.08.014","article-title":"Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells [J]","volume":"361","author":"Douka","year":"2023","journal-title":"J. Control. Release"},{"issue":"7963","key":"10.1016\/j.jconrel.2026.115170_bb0985","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer [J]","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb0990","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1016\/j.ymthe.2022.07.007","article-title":"mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells [J]","volume":"30","author":"Bevers","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb0995","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery [J]","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102803","article-title":"Spleen-targeted mRNA delivery via long-chain PEGylated lipids at low molar ratio enhances antitumor immunity against melanoma [J]","volume":"37","author":"Liu","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7607","key":"10.1016\/j.jconrel.2026.115170_bb1005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy [J]","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb1010","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice [J]","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115170_bb1015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs [J]","volume":"345","author":"LoPresti","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb1020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41563-025-02331-6","article-title":"Peptide codes for organ-selective mRNA delivery [J]","volume":"25","author":"Chang","year":"2026","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115170_bb1025","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1021\/acs.nanolett.9b04426","article-title":"Quantitating endosomal escape of a library of polymers for mRNA delivery [J]","volume":"20","author":"Jiang","year":"2020","journal-title":"Nano Lett."},{"issue":"50","key":"10.1016\/j.jconrel.2026.115170_bb1030","doi-asserted-by":"crossref","first-page":"21321","DOI":"10.1021\/jacs.1c09822","article-title":"Zwitterionic phospholipidation of cationic polymers facilitates systemic mRNA delivery to spleen and lymph nodes [J]","volume":"143","author":"Liu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb1035","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3390\/jcm9072309","article-title":"Inner ear gene therapies take off: current promises and future challenges [J]","volume":"9","author":"Delmaghani","year":"2020","journal-title":"J. Clin. Med."},{"issue":"755","key":"10.1016\/j.jconrel.2026.115170_bb1040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn0689","article-title":"Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation [J]","volume":"16","author":"Zhu","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb1045","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1038\/s41467-023-40476-7","article-title":"Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo [J]","volume":"14","author":"Tao","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115170_bb1050","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ymthe.2018.03.004","article-title":"Regeneration of cochlear hair cells and hearing recovery through Hes1 modulation with siRNA nanoparticles in adult guinea pigs [J]","volume":"26","author":"Du","year":"2018","journal-title":"Mol. Ther."},{"issue":"44","key":"10.1016\/j.jconrel.2026.115170_bb1055","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401445","article-title":"Tuning lipid nanoparticles for RNA delivery to extrahepatic organs [J]","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115170_bb1060","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","article-title":"In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles [J]","volume":"23","author":"Shi","year":"2023","journal-title":"Nano Lett."},{"issue":"6656","key":"10.1016\/j.jconrel.2026.115170_bb1065","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery [J]","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.jconrel.2026.115170_bb1070","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1021\/jacs.2c02706","article-title":"Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment [J]","volume":"144","author":"Xue","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"49","key":"10.1016\/j.jconrel.2026.115170_bb1075","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1021\/jacs.8b08976","article-title":"Nanoparticles that deliver RNA to bone marrow identified by in vivo directed evolution [J]","volume":"140","author":"Sago","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115170_bb1080","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/s43587-025-00968-1","article-title":"ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis [J]","volume":"5","author":"Wang","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.jconrel.2026.115170_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115446","article-title":"Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome [J]","volume":"214","author":"Mrksich","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115170_bb1090","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1021\/acsnano.4c02400","article-title":"Overcoming endosomal escape barriers in gene drug delivery using de novo designed pH-responsive peptides [J]","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115170_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102506","article-title":"Strategies and mechanisms for endosomal escape of therapeutic nucleic acids [J]","volume":"81","author":"Grau","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115170_bb1100","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jconrel.2022.12.008","article-title":"Engineering poly- and micelleplexes for nucleic acid delivery \u2013 A reflection on their endosomal escape [J]","volume":"353","author":"Winkeljann","year":"2023","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115170_bb1105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41434-021-00243-z","article-title":"Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions [J]","volume":"28","author":"Riyad","year":"2021","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115170_bb1110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.20517\/evcna.2024.19","article-title":"Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design [J]","volume":"5","author":"Hagedorn","year":"2024","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115170_bb1115","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/s41467-025-59377-y","article-title":"Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors [J]","volume":"16","author":"Liang","year":"2025","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.jconrel.2026.115170_bb1120","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0730","article-title":"Lipid nanoparticles for mRNA delivery in brain via systemic administration [J]","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"issue":"10097","key":"10.1016\/j.jconrel.2026.115170_bb1125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial [J]","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"issue":"33","key":"10.1016\/j.jconrel.2026.115170_bb1130","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202403935","article-title":"Membrane fusion-mediated loading of therapeutic siRNA into exosome for tissue-specific application [J]","volume":"36","author":"Xie","year":"2024","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115170_bb1135","doi-asserted-by":"crossref","first-page":"eabd6740","DOI":"10.1126\/sciadv.abd6740","article-title":"Injectable hydrogel with MSNs\/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs [J]","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:17:55Z","timestamp":1787804275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926005730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":227,"alternative-id":["S0168365926005730"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115170","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in RNA delivery to extrahepatic tissues and cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115170"}}